XpresSpa Group, Inc. (NASDAQ:XSPA) traded at $1.3 at last check on Tuesday, May 04, made a downturn move of -5.02% on its previous day’s price.
Looking at the stock we see that its previous close was $1.37 and the beta (5Y monthly) reads 2.32 with the day’s price range being $1.2600 – 1.3500. The company has a trailing 12-month PE ratio of 0. In terms of its 52-week price range, XSPA has a high of $8.82 and a low of $1.13. The company’s stock has gained about -17.96% over that past 30 days.
XpresSpa Group, Inc. has a market cap of $146.3 Million and is expected to release its quarterly earnings report on March 31, 2021. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the XSPA stock to lose ahead of the earnings release. Estimates by analysts give the company expected earnings per share (EPS) of -$0.05, with the EPS growth for the year raised at -$0.17 for 2021 and -$0.02 for next year. These figures represent -0.92% and -0.88% growth in EPS for the two years respectively.
On the other hand, looking at the outlook for the XSPA stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, none have rated the XpresSpa Group, Inc. (XSPA) stock as a Hold, while 1 rate it as a Buy. None analyst(s) rate it as outperform while none of them rated it as underperform, whereas none suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the XSPA stock currently stands at 0, and the most recent price level today is -9.29% off its SMA20 and -22.81% from its 50-day simple moving average. The RSI (14) is pointing at 35.51 while the volatility over the past week is 5.13% and jumps to 6.98% over the past one month. The beta value is 2.32, while the average true range (ATR) is currently pointing at 0.11. The average price target for the stock over the next 12 months is $3.5, with the estimates having a low of $3.5 and a high of $3.5. These price ends are 169.23% and +169.23% off the today’s price level respectively, although investors could be excited at the prospect of a +169.23% if the XSPA share price touches on the median price of $3.5.
Let’s briefly compare XpresSpa Group, Inc. (XSPA) stock to its peers. We find that today’s price change of -5.02% and -8.67% over the past 12 months for XSPA competes that of Teladoc Health Inc (TDOC), which has seen its stock price fall -5.78% in the latest trading session and is -3.67% over the last one year. Another of its peers Novocure Ltd Ord Sh (NVCR) has dropped -4.06% today, and was +234.92% up over the past year, while Avantor Inc (AVTR) is also down -5.02% yet, while its price remains in the red at -8.67% over the same period. XpresSpa Group, Inc. has a P/E ratio of 0 compared to Teladoc Health Inc’s 0 and Novocure Ltd Ord Sh’s 1929.14. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at -1.21% and -0.62%, respectively, in early deals.
Coming back to XpresSpa Group, Inc. (NASDAQ:XSPA), we note that the average 3-month trading volume was 8.11 Million, while that of the preceding 10-day period stands at 1.73 Million. Current shares outstanding are 105.31 Million.
According to data from Thomson Reuters, insiders hold 0.19% of the company’s shares while institutions hold 10.95%. The data shows that short shares as of April 14, 2021, stood at 13.02 Million at a short ratio of 2.25. This represents a 12.37% short interest in shares outstanding on April 14, 2021. Shares short dropped in April from the previous month at 15.07 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock +15.13% up in year-to-date price movement.